PITCH - Impacting Hereditary Cancer Testing
Part of paid clinical trials in Lexington, Kentucky.
- Sponsor
- Rachel Miller
- Study ID
- NCT07090109
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Genetic Counseling
- Genetic Testing
- Ovarian Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Genetic testing education video — BEHAVIORALpatient education video about genetic testing for hereditary cancers
Study Details
The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are: * Did the video change participants' knowledge and attitudes about genetic testing? * Did participants make an informed choice about pursuing genetic testing? Participants will: * Complete a baseline survey * View educational video * Complete follow-up survey
Key Dates
- Start date
- May 31, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Educational VideoParticipants will complete a survey before and after viewing an educational video
Primary Outcome Measure
Change in Multi-Dimensional Measure of Informed Choice (MMIC) - Cancer Knowledge Scale [ Time Frame: Baseline and post intervention (approximately 30 minutes) ]
Central Contacts
- Justine Pickarski859-323-9697
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Kentucky | Lexington | Kentucky | 40506 | Justine Pickarski |
Find similar trials in Lexington, KY
Related Studies
- Transvaginal Ultrasonography as a Screening Method for Ovarian CancerRecruiting · John R van Nagell · Lexington, Kentucky
- TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid TumorsPHASE1/PHASE2 · Recruiting · Portage Biotech · Los Angeles, California
- First in Human Study of TORL-1-23 in Participants With Advanced CancerPHASE1 · Recruiting · TORL Biotherapeutics, LLC · Fullerton, California
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California